Women with a personal or family history of breast or ovarian cancer are increasingly presenting for genetic cancer risk assessment (GCRA). To explore the personal and family impact of GCRA, four focus groups were conducted of women seen for risk assessment. Participants were 22 primarily non-Latina White women with a personal or family history of breast or ovarian cancer. Analysis of the data identified new themes related to balancing time to assimilate risk information with the need to make timely healthcare decisions, physicians’ lack of sufficient genetic knowledge, and concern for daughters regardless of the daughters’ age. Other themes related to protecting others, knowledge as empowerment, reassessing personal attribution of cancer risk, managing uncertainty, reappraising body image, and experiencing divergent family responses to communication of cancer risk and healthcare decisions. Understanding the personal and family impact of GCRA may enable genetics professionals to tailor their counseling efforts to better meet the needs of these women. Additional research is needed to extend these findings and identify interventions to support positive outcomes of GCRA.
This is a preview of subscription content, log in to check access.
Anderson, B. O. (2001). Prophylactic surgery to reduce breast cancer risk: a brief literature review. The Breast Journal, 7(5), 321–330.
Antoniou, A., Pharoah, P. D., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., et al. (2003). Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 Studies. American Journal of Human Genetics, 72(5), 1117–1130.
ASCO. (2003). American society of clinical oncology policy statement update: genetic testing for cancer susceptibility. Journal of Clinical Oncology, 21(12), 2397–2406.
Bastani, R., Maxwell, A. E., Bradford, C., Das, I. P., & Yan, K. X. (1999). Tailored risk notification for women with a family history of breast cancer. Preventive Medicine, 29(5), 355–364.
Bish, A., Sutton, S., Jacobs, C., Levene, S., Ramirez, A., & Hodgson, S. (2002). Changes in psychological distress after cancer genetic counselling: a comparison of affected and unaffected women. British Journal of Cancer, 86(1), 43–50.
Calderon-Margalit, R., & Paltiel, O. (2004). Prevention of breast cancer in women who carry BRCA1 or BRCA2 mutations: a critical review of the literature. International Journal of Cancer, 112(3), 357–364.
Champion, V. L. (1987). The relationship of breast self-examination to health belief model variables. Research in Nursing & Health, 10(6), 375–382.
Champion, V. L. (1993). Instrument refinement for breast cancer screening behaviors. Nursing Research, 42(3), 139–143.
Champion, V. L., & Scott, C. R. (1997). Reliability and validity of breast cancer screening belief scales in African American women. Nursing Research, 46(6), 331–337.
Claes, E., Evers-Kiebooms, G., Boogaerts, A., Decruyenaere, M., Denayer, L., & Legius, E. (2003). Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. American Journal of Medical Genetics, 116(1), 11–19.
Costalas, J. W., Itzen, M., Malick, J., Babb, J. S., Bove, B., Godwin, A. K., et al. (2003). Communication of BRCA1 and BRCA2 results to at-risk relatives: a cancer risk assessment program's experience. American Journal of Medical Genetics, 119C(1), 11–18.
Croyle, R. T., Smith, K. R., Botkin, J. R., Baty, B., & Nash, J. (1997). Psychological responses to BRCA1 mutation testing: preliminary findings. Health Psychology, 16(1), 63–72.
Cull, A., Anderson, E. D., Campbell, S., Mackay, J., Smyth, E., & Steel, M. (1999). The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress. British Journal of Cancer, 79(3–4), 501–508.
Daly, M. B., Axibund, J. E., Bryant, E., Buys, S., Eng, C., Esserman, L. J., et al. (2007). NCCN Practice Guidelines in Oncology: Genetic/familial high-risk assessment: breast and ovarian. v.1.2007. Retrieved March 22, 2007, from https://doi.org/www.nccn.org/professionals/physician_gls/PDF/genetics_screening.pdf
Easton, D. F., Ford, D., & Bishop, D. T. (1995). Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast cancer linkage consortium. American Journal of Human Genetics, 56, 265–271.
Ferrell, B. R., Grant, M. M., Funk, B. M., Otis-Green, S. A., & Garcia, N. J. (1998). Quality of life in breast cancer survivors: implications for developing support services. Oncology Nursing Forum, 25, 887–895.
Ford, D., Easton, D. F., Stratton, M., Narod, S., Goldgar, D., Devilee, P., et al. (1998). Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. American Journal of Human Genetics, 62, 676–689.
Forrest, K., Simpson, S. A., Wilson, B. J., van Teijlingen, E. R., McKee, L., Haites, N., et al. (2003). To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clinical Genetics, 64(4), 317–326.
Frank, T. S., Deffenbaugh, A. M., Reid, J. E., Hulick, M., Ward, B. E., Lingenfelter, B., et al. (2002). Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10, 000 individuals. Journal of Clinical Oncology, 20(6), 1480–1490.
Frost, M. H., Schaid, D. J., Sellers, T. A., Slezak, J. M., Arnold, P. G., Woods, E. J., et al. (2000). Long-term satisfaction and psychological and social function following bilateral prophylactic mastectomy. Journal of the American Medical Association, 284(3), 319–324.
Frost, M. H., Slezak, J. M., Tran, N. V., Williams, C. I., Johnson, J. L., Woods, J. E., et al. (2005). Satisfaction after contralateral prophylactic mastectomy: the significance of mastectomy type, reconstructive complications, and body appearance. Journal of Clinical Oncology, 23(31), 7849–7856.
Fry, A., Cull, A., Appleton, S., Rush, R., Holloway, S., Gorman, D., et al. (2003). A randomised controlled trial of breast cancer genetics services in South East Scotland: psychological impact. British Journal of Cancer, 89(4), 653–659.
Geller, G., Doksum, T., Bernhardt, B. A., & Metz, S. A. (1999). Participation in breast cancer susceptibility testing protocols: influence of recruitment source, altruism, and family involvement on women's decisions. Cancer Epidemiology Biomarkers & Prevention, 8(4 Pt 2), 377–383.
Giger, J., & Davidhizar, R. (2004). Transcultural nursing: assessment & intervention (4th ed.). St. Louis: Mosby.
Green, J., Richards, M., Murton, F., Statham, H., & Hallowell, N. (1997). Family communication and genetic counseling: the case of hereditary breast and ovarian cancer. Journal of Genetic Counseling, 6, 45–60.
Halbert, C. H., Schwartz, M. D., Wenzel, L., Narod, S., Peshkin, B. N., Cella, D., et al. (2004). Predictors of cognitive appraisals following genetic testing for BRCA1 and BRCA2 mutations. Journal of Behavioral Medicine, 27(4), 373–392.
Hartmann, L. C., Sellers, T. A., Schaid, D. J., Frank, T. S., Soderberg, C. L., Sitta, D. L., et al. (2001). Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers. Journal of the National Cancer Institute, 93(21), 1633–1637.
Hughes, C., Lynch, H., Durham, C., Snyder, C., Lemon, S., Narod, S., et al. (1999). Communication of BRCA1/2 test results in hereditary breast cancer families. Cancer Research, Therapy and Control, 8, 51–59.
Hughes, C., Lerman, C., Schwartz, M., Peshkin, B., Wenzel, L., Narod, S., et al. (2002). All in the family: Evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results. American Journal of Medical Genetics, 107(2), 143–150.
Julian-Reynier, C., Eisinger, F., Vennin, P., Chabal, F., Aurran, Y., Nogues, C., et al. (1996). Attitudes towards cancer predictive testing and transmission of information to the family. Journal of Medical Genetics, 33(9), 731–736.
Kauff, N. D., & Barakat, R. R. (2007). Risk-reducing salpingo-oophorectomy in patients with germline mutations in BRCA1 or BRCA2. Journal of Clinical Oncology, 25(20), 2921–2927.
Kauff, N. D., Domchek, S. M., Friebel, T. M., Robson, M. E., Lee, J., Garber, J. E., et al. (2008). Risk-reducing salpingo-oophorectomy for the prevention of BRCA1- and BRCA2-associated breast and gynecologic cancer: a multicenter, prospective study. Journal of Clinical Oncology, 26(8), 1331–1337.
Kelly, K., Leventhal, H., Andrykowski, M., Toppmeyer, D., Much, J., Dermody, J., et al. (2005). Using the common sense model to understand perceived cancer risk in individuals testing for BRCA1/2 mutations. Psychooncology, 14(1), 34–48.
Krippendorff, K. (1990). Content analysis: an introduction to its methodology (Vol. 5). Newbury Park, London, New Delhi: Sage.
Krueger, R. A. (1988). Focus groups: a practical guide for applied research (1st ed.). Newbury Park: Sage.
Lerman, C., & Croyle, R. T. (1996). Emotional and behavioral responses to genetic testing to cancer. Oncology, 19, 191–199.
Lerman, C., Daly, M., Masny, A., & Balshem, A. (1994). Attitudes about genetic testing for breast-ovarian cancer susceptibility. Journal of Clinical Oncology, 12, 843–850.
Lerman, C., Seay, J., Balshem, A., & Audrain, J. (1995). Interest in genetic testing among first-degree relatives of breast cancer patients. American Journal of Medical Genetics, 57(3), 385–392.
Liede, A., Karlan, B. Y., & Narod, S. A. (2004). Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. Journal of Clinical Oncology, 22(4), 735–742.
Lodder, L., Frest, P. G., Trijsburg, R. W., Meijers-Heijboer, E. J., Klijn, J. G. M., Duivenvoorden, H. J., et al. (2001). Psychological impact of receiving a BRCA1/BRCA2 test result. American Journal of Medical Genetics, 98(1), 15–24.
Loveland-Cherry, C. J., & Bomar, P. J. (2004). Family health promotion and health protection. In P. J. Bomar (Ed.), Promoting health in families applying family research and theory to nursing practice (Vol. 3, pp. 61–89). Philadelphia: Saunders.
MacDonald, D. J., Choi, J., Ferrell, B., Sand, S., McCaffrey, S., Blazer, K. R., et al. (2002). Concerns of women presenting to a comprehensive cancer center for genetic cancer risk assessment. Journal of Medical Genetics, 39, 526–530.
MacDonald, D. J., Sarna, L., Uman, G. C., Grant, M., & Weitzel, J. N. (2005). Health beliefs of women with and without breast cancer seeking genetic cancer risk assessment. Cancer Nursing, 28(5), 372–379.
MacDonald, D. J., Sarna, L., van Servellen, G., Bastani, R., Giger, J. N., & Weitzel, J. N. (2007). Selection of family members for communication of cancer risk and barriers to this communication before and after genetic cancer risk assessment. Genetics in Medicine, 9(5), 275–282.
MacDonald, D. J., Sarna, L., Giger, J. N., Bastani, R., van Servellen, G., & Weitzel, J. N. (2008). Comparison of Latina and non-Latina White women’s beliefs about communicating genetic cancer risk to relatives. Journal of Health Communication, 13(5), 465–479.
Manne, S., Audrain, J., Schwartz, M., Main, D., Finch, C., & Lerman, C. (2004). Associations between relationship support and psychological reactions of participants and partners to BRCA1 and BRCA2 testing in a clinic-based sample. Annals of Behavioral Medicine, 28(3), 211–225.
McGivern, B., Everett, J., Yager, G. G., Baumiller, R. C., Hafertepen, A., & Saal, H. M. (2004). Family communication about positive BRCA1 and BRCA2 genetic test results. Genetic Medicine, 6(6), 503–509.
Meiser, B. (2005). Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psychooncology, 14(12), 1060–1074.
Mellon, S., Berry-Bobovski, L., Gold, R., Levin, N., & Tainsky, M. A. (2006). Communication and decision-making about seeking inherited cancer risk information: findings from female survivor-relative focus groups. Psychooncology, 15(3), 193–208.
Metcalfe, K. A., Esplen, M. J., Goel, V., & Narod, S. A. (2004). Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy. Psychooncology, 13(1), 14–25.
Metcalfe, K. A., Lynch, H. T., Ghadirian, P., Tung, N., Olivotto, I., Warner, E., et al. (2004). Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers. Journal of Clinical Oncology, 22(12), 2328–2335.
Morgan, D. L. (1997). Focus groups as qualitative research (2nd ed.). Newberry Park: Sage.
Neuendorf, K. (2002). The content analysis guidebook. Thousand Oaks: Sage.
Patenaude, A. F., Dorval, M., DiGianni, L. S., Schneider, K. A., Chittenden, A., & Garber, J. E. (2006). Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. Journal of Clinical Oncology, 24(4), 700–706.
Phelps, C., Wood, F., Bennett, P., Brain, K., & Gray, J. (2007). Knowledge and expectations of women undergoing cancer genetic risk assessment: a qualitative analysis of free-text questionnaire comments. Journal of Genetic Counseling, 16(4), 505–514.
Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van't Veer, L., Garber, J. E., et al. (2004). Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE study group. Journal of Clinical Oncology, 22(6), 1055–1062.
Robson, M., Svahn, T., McCormick, B., Borgen, P., Hudis, C. A., Norton, L., et al. (2005). Appropriateness of breast-conserving treatment of breast carcinoma in women with germline mutations in BRCA1 or BRCA2: A clinic-based series. Cancer, 103(1), 44–51.
Rubinstein, W. S. (2004). Hereditary breast cancer in Jews. Familial Cancer, 3(3–4), 249–257.
Sarna, L., Tae, Y. S., Kim, Y. H., Brecht, M. L., & Maxwell, A. E. (2001). Cancer screening among Korean Americans. Cancer Practice, 9(3), 134–140.
Schwartz, M. D., Valdimarsdottir, H. B., DeMarco, T. A., Peshkin, B. N., Lawrence, W., Rispoli, J., et al. (2009). Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: impact on measures of decision making and satisfaction. Health Psychology, 28(1), 11–19.
Sermijn, E., Goelen, G., Teugels, E., Kaufman, L., Bonduelle, M., Neyns, B., et al. (2004). The impact of proband mediated information dissemination in families with a BRCA1/2 gene mutation. Journal of Medical Genetics, 41(3), E23.
Stephenson, J. (1999). Genetic test information fears unfounded. Journal of the American Medical Association, 282, 2197–2198.
Stewart, D. W., & Shamdasani, P. N. (1990). Focus groups: theory and practice (1st ed.). Newberry Park: Sage.
Tercyak, K. P., Hughes, C., Main, D., Snyder, C., Lynch, J. F., Lynch, H. T., et al. (2001). Parental communication of BRCA1/2 genetic test results to children. Patient Education and Counseling, 42, 213–224.
Tercyak, K. P., Peshkin, B. N., Brogan, B. M., DeMarco, T., Pennanen, M. F., Willey, S. C., et al. (2007). Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing. Journal of Clinical Oncology, 25(3), 285–291.
Tercyak, K. P., Peshkin, B., DeMarco, T., Brogan, B., & Lerman, C. (2002). Parent-child factors and their effect on communicating BRCA1/2 test results to children. Patient Education and Couseling, 47(2), 145.
The Breast Cancer Linkage Consortium. (1999). Cancer risks in BRCA2 mutation carriers. Journal of the National Cancer Institute, 91, 1310–1316.
van Dijk, S., van Roosmalen, M. S., Otten, W., & Stalmeier, P. F. M. (2008). Decision making regarding prophylactic mastectomy: stability of preferences and the impact of anticipated feelings of regret. Journal of Clinical Oncology, 26(14), 2358–2363.
van Oostrom, I., Meijers-Heijboer, H., Ladder, L. N., Duivenvoorden, H. J., van Gool, A. R., Seynaeve, C., et al. (2003). Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. Journal of Clinical Oncology, 21(20), 3867–3874.
Wainberg, S., & Husted, J. (2004). Utilization of screening and preventive surgery among unaffected carriers of a BRCA1 or BRCA2 gene mutation. Cancer Epidemiology Biomarkers & Prevention, 13(12), 1989–1995.
Weitzel, J. N., McCaffrey, S. M., Nedelcu, R., MacDonald, D. J., Blazer, K. R., & Cullinane, C. A. (2003). Effect of genetic cancer risk assessment on surgical decisions at breast cancer diagnosis. Archives of Surgery, 138(12), 1323–1328. discussion 1329.
This research was supported by funds from the California Breast Cancer Research Program of the University of California, Grant Number 5BP-0051 (D. MacDonald, PI) and in part by funds received under Grant Agreement No. 99-86874 with the California Department of Health Services, Cancer Research Section (J. Weitzel, PI). The authors thank Janelle Hilario and Shawntel Payton for editorial assistance.
About this article
Cite this article
MacDonald, D.J., Sarna, L., Weitzel, J.N. et al. Women’s Perceptions of the Personal and Family Impact of Genetic Cancer Risk Assessment: Focus Group Findings. J Genet Counsel 19, 148–160 (2010). https://doi.org/10.1007/s10897-009-9267-3
- Genetic risk
- Family impact
- Risk communication
- Hereditary cancer
- Genetic counseling
- Focus groups